CHAMGAP
APPROVEDReviewed and approved by the Chamgap Editorial Team (2026-07-19). The draft was written by AI, the existence of all 4 cited sources was verified at the original page, and the verdict passed blind grading and adversarial audit. Methodology v0.6.
Verdict No. 620 · Search date 2026-07-19 · Methodology v0.6

Hyland's Calms Forté,
does it really help with Relief of stress-related insomnia and restlessness with restful sleep free of next-day drowsiness?

30-Second Summary
F
Evidence Grade F · 10 · Safety caution
The official label acknowledges no scientific efficacy evidence, and no product trial establishes restful sleep, relief of restlessness, or freedom from next-day drowsiness
What the
research shows
Hyland's Calms Forté is rated F for claims of relieving stress-related insomnia and restlessness while providing restful sleep without next-day drowsiness. The current DailyMed label itself states that the product has not been evaluated by FDA for safety or efficacy and that FDA is not aware of scientific evidence supporting homeopathy as effective. No reliable product-specific randomized clinical efficacy study of this nine-ingredient 3X and 4X combination was found, and a systematic review of homeopathy for insomnia found no significant between-group difference in any of four placebo-controlled trials. The no-next-day-drowsiness claim is likewise unproven without a product-specific comparative trial. This is a different multi-ingredient formulation from the single Coffea cruda product in verdict 600 and follows the homeopathy-class calibration in verdicts 563, 577, and 586.
What the
ads claim
Package terms such as sleep aid, non-habit forming, and stress relief can be interpreted as scientifically proven restful sleep, treatment of restlessness, and no next-day drowsiness. Label listing and traditional homeopathic claims do not establish product-specific efficacy or next-day functional superiority over active sleep medicines.
*

Useful facts when choosing a product

  • Calms Forté is a nine-ingredient homeopathic combination tablet listing oat, calcium phosphate, chamomile, iron phosphate, hops, potassium phosphate, magnesium phosphate, sodium phosphate, and passionflower at 3X or 4X dilutions.
  • United States DailyMed classifies it as an unapproved homeopathic product and states that FDA has not evaluated its safety or efficacy and is not aware of scientific evidence supporting homeopathy as effective.
  • The current label directs people aged 12 years and older to take one to three tablets before bed for occasional sleeplessness and to contact a physician if symptoms persist beyond seven days or worsen.
  • The tablets contain lactose and starches, while allergy or intolerance, manufacturing variation, co-use with other sedating products, and delayed effective insomnia care remain separate considerations.
Gap Measurement · Verdict 620 · F 10
What advertising claims
What independent, higher-quality research supports
△ GAP
01

What the research actually shows

The current DailyMed label lists a 3X and 4X combination of Avena sativa, Calcarea phosphorica, Chamomilla, Ferrum phosphoricum, Humulus lupulus, Kali phosphoricum, Magnesia phosphorica, Natrum phosphoricum, and Passiflora and claims temporary relief of occasional sleeplessness, restlessness, and accompanying stress symptoms. The same label states that claims are based on traditional homeopathic practice rather than accepted medical evidence and were not evaluated by FDA. A targeted search by product name and composition found no reliable product-specific randomized trial. Cooper and Relton reviewed four placebo-controlled trials of homeopathy for insomnia and found no significant between-group difference in any trial, while the larger-trial and higher-quality subset in the analysis by Shang and colleagues found effects compatible with placebo. Coffea cruda in verdict 600 is a single ingredient and differs from this nine-ingredient formulation; Ignatia in 563, Arnica in 577, and Rescue Remedy in 586 are different products but provide class calibration through repeated refutation.

02

Why this is classified as F (10)

The official product label acknowledges absent scientific efficacy evidence and lack of FDA evaluation, and no reliable clinical efficacy trial specific to the nine-ingredient combination exists. Four repeatedly null placebo-controlled insomnia-homeopathy trials and placebo-compatible results from higher-quality homeopathy evidence yield F with 10 points. Low-dilution ingredients, lactose, manufacturing variation, and delayed care remain separate safety considerations.

Counterpoint. Brief stress-related sleeplessness may resolve after use, but this does not establish a product-specific effect. Insomnia lasting more than two weeks, impairing daytime function, or suggesting depression, anxiety, sleep apnea, or a medication problem calls for cognitive behavioral therapy and evaluation of underlying causes.

Rejudgment record. New verdict — Applied the official label's statement of absent scientific efficacy evidence and no FDA evaluation, the absence of a reliable Calms Forté-specific clinical trial, repeated null placebo-controlled insomnia-homeopathy trials, and placebo-compatible higher-quality homeopathy evidence to the F standard

Sub-claim grades by effect

This ingredient is marketed for several effects. A single overall grade blends strong and weak claims together, so each effect is graded separately here. The overall grade reflects the strongest disconfirming or core claim.

Effect (sub-claim)GradeBasis
Relief of stress-related insomnia and restlessnessFNo reliable product-specific trial exists, placebo-controlled insomnia-homeopathy trials are repeatedly null, and the official label acknowledges absent scientific efficacy evidence.
Restful sleep without next-day drowsinessFNo product-specific comparative next-day-function trial exists, and sleep efficacy itself is unproven, so the no-drowsiness superiority claim is unsupported.

Cross-check — Codex and Claude

This verdict was drafted by Codex through literature review and source-existence checks, cross-checked through blind grading and adversarial audit, and settled by reapplying the methodology boundary rules. Cases with split grades were resolved through rejudgment.
03

Evidence Table

StudyDesignSampleFundingEndpointResultWeight
DailyMed Calms Forté label, revised 2025Official product-label and regulatory-status review9Hyland's product label posted by DailyMedLabel claims, ingredients and dilutions, directions, and regulatory disclaimerThe label states no FDA safety or efficacy evaluation and no known scientific evidence supporting homeopathy, and classifies the product as unapproved homeopathy.Key direct evidence of product-specific regulatory and evidence status
Cooper KL, Relton C. 2010Systematic review of homeopathy for insomnia4Academic research at the University of SheffieldSleep duration, sleep quality, and insomnia symptomsNo trial showed a statistically significant difference between homeopathy and placebo.Key synthesis of repeated null findings for insomnia
Shang A et al. 2005Comparative meta-analysis of placebo-controlled homeopathy and conventional-medicine trials110Swiss public evaluation programCondition-specific clinical effectsEffects in less biased homeopathy trials were compatible with placebo.Class-wide refuting evidence
§

Receipt — 4 References

All 4 cited sources were verified for existence at the original page (as of 2026-07-19).

DailyMed. CALMS FORTE—Avena sativa flowering top, tribasic calcium phosphate, Matricaria recutita, ferrosoferric phosphate, hops, potassium phosphate, magnesium phosphate, sodium phosphate, and Passiflora incarnata flower tablet. Revised April 2025. PMID: none. DOI: none.
checked
Cooper KL, Relton C. Homeopathy for insomnia: a systematic review of research evidence. Sleep Med Rev. 2010;14(5):329-337. PMID: 20223686. DOI: 10.1016/j.smrv.2009.11.005.
checked
Shang A, Huwiler-Müntener K, Nartey L, et al. Are the clinical effects of homoeopathy placebo effects? Comparative study of placebo-controlled trials of homoeopathy and allopathy. Lancet. 2005;366(9487):726-732. PMID: 16125589. DOI: 10.1016/S0140-6736(05)67177-2.
checked
U.S. Food and Drug Administration. Homeopathic Products. Updated December 10, 2025. PMID: none. DOI: none.
checked
Draft and rewrite: Codex (AI) · Verification: Codex blind grading and adversarial audit · Final adjudication: Claude
Reviewed and approved: Chamgap Editorial Team · Approval date: 2026-07-19 · Corrections: none

Cite this verdict

Hyland's Calms Forté x relief of stress-related insomnia and restlessness without next-day drowsiness Evidence Grade F card
[Chamgap] Hyland's Calms Forté x relief of stress-related insomnia and restlessness without next-day drowsiness — Evidence Grade F·10. 4 cited sources checked. Source: https://chamgap.com/en/verdicts/sleep/hylands-calms-forte-stress-insomnia-restlessness-no-next-day-drowsiness/ · CC BY 4.0

CC BY 4.0 — free to use with attribution; do not distort grades, numbers, or verdict meaning.

!

What this document does and does not do

Chamgap is an information source. It reports what research has and has not confirmed; it does not tell readers what to take or buy. That decision belongs to readers and, when needed, medical or legal professionals. This verdict reflects literature available up to the search date and may change as new research appears. Nothing here is medical advice.